Physician profile
Patrick J Gallus
NPI 1902861479
$800.02
in general payments reported to CMS, 2019-2025
15 companies · $416 in 2025
The $416 reported for 2025 was more than what 90% of Emergency Medical Services providers received nationally (typical 2025 total: $70.35).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.85 · 2024: $371 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $151.49 | 2024 | Mounjaro, Jardiance |
| Amgen INC. | $132.38 | 2024-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.81 | 2024-2025 | Jardiance |
| Abbvie INC. | $80.51 | 2024-2025 | |
| Exact Sciences Corporation | $56.02 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $51.45 | 2024-2025 | Ozempic, Rybelsus |
| Medtronic, INC. | $47.61 | 2025 | Minimed 780g, Inceptiv |
| Abiomed | $41.28 | 2025 | |
| Lundbeck LLC | $33.53 | 2024 | Rexulti |
| Inspire Medical Systems, INC. | $20.10 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $17.05 | 2025 | Trelegy Ellipta |
| Kyowa Kirin, INC. | $16.29 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.55 | 2025 | |
| Pfizer INC. | $14.10 | 2025 | |
| Alkermes, INC. | $12.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Gallus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.